Watershed Therapeutics: Funding, Investors & Team (Oct 2026)
Watershed Therapeutics develops a novel, targeted drug-delivery platform for bladder diseases. The initial aim is to stop recurring urinary tract infections. The therapy can be tailored to help patients with overactive bladder, painful bladder syndrome, and bladder cancer.
Watershed Therapeutics has raised $300k across 1 funding round on record, the most recent an undisclosed round of $300k announced in Apr 2026.
That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Watershed Therapeutics Company Profile and Key Stats
Latest funding round on record: Apr 2026.
Watershed Therapeutics Funding Rounds
Watershed Therapeutics Founders and Leadership Team
Contact details for the Watershed Therapeutics team: 1 of 1 has an email address on file.
Start 14-day free trial →Watershed Therapeutics Funding Compared to Other Biotechnology Startups
Watershed Therapeutics' latest round of $300k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Watershed Therapeutics in Biotechnology and Los Altos
Companies Similar to Watershed Therapeutics
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Watershed Therapeutics Funding FAQs
What does Watershed Therapeutics do?
Watershed Therapeutics develops a novel, targeted drug-delivery platform for bladder diseases. The initial aim is to stop recurring urinary tract infections. The therapy can be tailored to help patients with overactive bladder, painful bladder syndrome, and bladder cancer.
How much funding has Watershed Therapeutics raised?
Watershed Therapeutics has raised $300k across 1 round on record. The most recent is an undisclosed round of $300k announced in Apr 2026.
When did Watershed Therapeutics last raise funding?
Watershed Therapeutics' most recent funding round on record is an undisclosed round of $300k, announced in Apr 2026.
Who founded Watershed Therapeutics?
FundedIQ lists Topher Kinsella (Founder) at Watershed Therapeutics.
Where is Watershed Therapeutics headquartered?
Watershed Therapeutics is based in Los Altos, California, United States.
How many employees does Watershed Therapeutics have?
Watershed Therapeutics is in the 1-10 employee band.
How does Watershed Therapeutics' funding compare to other Biotechnology startups?
Watershed Therapeutics' latest round of $300k is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Watershed Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Watershed Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.